The Netherlands: LSP closes LSP 7 fund at over €1bn prior to EQT tie-up

René Kuijten, managing partner, LSP

European life sciences and health care investment firm, LSP, has raised over €1bn (US$1.13bn) for its flagship fund LSP 7, the largest life sciences venture capital fund so far closed in Europe. The fund aims to invest in companies developing new drug therapies and medical technologies, to help ensure that their scientific innovations benefit patients….

You must be a HMI Subscriber to view this content.

Subscribe Now »